These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27 related articles for article (PubMed ID: 2036817)
1. A comparative study of efficacy and safety of arformoterol and salbutamol nebulization as rescue therapy in acute non-severe asthma. Das SK; Biswas I; Bandyopadhyay AK; Bairagya TD; Bhattacharya S Indian J Pharmacol; 2011 Jul; 43(4):463-5. PubMed ID: 21845007 [TBL] [Abstract][Full Text] [Related]
2. Indacaterol, A Novel Once Daily Inhaled beta2-Adrenoreceptor Agonist. Roig J; Hernando R; Mora R Open Respir Med J; 2009 Mar; 3():27-30. PubMed ID: 19452036 [TBL] [Abstract][Full Text] [Related]
3. Systemic and bronchodilator effects of inhaled rac-formoterol in subjects with chronic obstructive pulmonary disease: a dose-response study. Whale CI; Sovani MP; Mortimer KJ; Harrison TW; Tattersfield AE Br J Clin Pharmacol; 2008 Jun; 65(6):841-7. PubMed ID: 18394012 [TBL] [Abstract][Full Text] [Related]
4. Hypokalaemia in healthy volunteers after single and multiple doses of formoterol or salbutamol. van den Berg BT; Louwerse RT; Luiken GJ; Jonkers RE; van Boxtel CJ Clin Drug Investig; 1998; 15(6):523-9. PubMed ID: 18370510 [TBL] [Abstract][Full Text] [Related]
5. A randomised, double-blind, placebo-controlled study to evaluate the role of formoterol in the management of acute asthma. Najafizadeh K; Sohrab Pour H; Ghadyanee M; Shiehmorteza M; Jamali M; Majdzadeh S Emerg Med J; 2007 May; 24(5):317-21. PubMed ID: 17452695 [TBL] [Abstract][Full Text] [Related]
6. Inhaled beta2-adrenoceptor agonists: cardiovascular safety in patients with obstructive lung disease. Cazzola M; Matera MG; Donner CF Drugs; 2005; 65(12):1595-610. PubMed ID: 16060696 [TBL] [Abstract][Full Text] [Related]
7. Inhaled short acting beta agonist use in COPD and the risk of acute myocardial infarction. Suissa S; Assimes T; Ernst P Thorax; 2003 Jan; 58(1):43-6. PubMed ID: 12511719 [TBL] [Abstract][Full Text] [Related]
8. Systemic effects of formoterol and salmeterol: a dose-response comparison in healthy subjects. Guhan AR; Cooper S; Oborne J; Lewis S; Bennett J; Tattersfield AE Thorax; 2000 Aug; 55(8):650-6. PubMed ID: 10899240 [TBL] [Abstract][Full Text] [Related]
9. Formoterol. An update of its pharmacological properties and therapeutic efficacy in the management of asthma. Bartow RA; Brogden RN Drugs; 1998 Feb; 55(2):303-22. PubMed ID: 9506248 [TBL] [Abstract][Full Text] [Related]